12,373 results match your criteria Journal of hypertension[Journal]


Relationship among long-term aircraft noise exposure, blood pressure profile, and arterial stiffness.

J Hypertens 2019 Feb 8. Epub 2019 Feb 8.

1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Kraków, Poland.

Objective: To assess the impact of long-term exposure to aircraft noise on blood pressure (BP), prevalence of arterial hypertension, and indices of asymptomatic organ damage.

Methods: Using acoustic maps, we selected and further compared people living (average 35 years) in areas exposed to high, more than 60 dB (n = 101), and low aircraft noise, less than 55 dB (n = 100). Medical history taking, office BP measurement, ambulatory BP monitoring, and echocardiographic and arterial stiffness measurements were performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002060DOI Listing
February 2019
1 Read

Impact of kidney transplantation on aortic stiffness and aortic stiffness index β0.

J Hypertens 2019 Feb 8. Epub 2019 Feb 8.

CHU de Québec Research Center, Hotel-Dieu de Québec Hospital, Division of Nephrology, Université Laval, Québec, Québec City, Canada.

Background: In chronic kidney disease, the enhanced aortic stiffness increases risk of cardiovascular events. Kidney transplantation (KTx) may improve aortic stiffness; however, it is unclear whether the improvement of aortic stiffness is merely the outcome of the reduction of blood pressure (BP) post-KTx. Furthermore, the long-term trajectory of aortic stiffness remains uncertain, as activation of the immune system may have a negative long-term impact on arterial wall property. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002058DOI Listing
February 2019
1 Read

Assessing the quality of guidelines for primary aldosteronism: which guidelines are worth applying in diverse settings?

J Hypertens 2019 Feb 4. Epub 2019 Feb 4.

Jueli Wu and Wenqing Tian are the first two authors contributed equally to the article.

Objective: To review the validity and applicability of clinical guidelines on the management of primary aldosteronism and to list their discrepancies to allow health-care providers and guideline developers to make informed decisions.

Design And Methods: Primary aldosteronism management guidelines, including specialist, subgroup, general guidelines written in English, were obtained from electronic databases. Appraisers independently extracted the data, and used the Appraisal Guidelines Research and Evaluation II (AGREE-II) tool and the Institute of Medicine (IOM) criteria to independently evaluate the methodological quality of the guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002046DOI Listing
February 2019
1 Read

Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism.

J Hypertens 2019 Mar;37(3):596-602

Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC.

Background: Constituitively high and nonsuppressible aldosterone levels are considered to be the hallmark of primary aldosteronism. We observed a high proportion of primary aldosteronism patients with surprisingly low aldosterone levels in peripheral veins during adrenal vein sampling (AVS) and sought to further characterize the phenomenon.

Methods: Database analysis of patients with primary aldosteronism at the University of Calgary who underwent AVS under intravenous sedation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001905DOI Listing
March 2019
2 Reads

Renin-dependent hypertension cured with percutaneous radiofrequency ablation.

J Hypertens 2019 Mar;37(3):653-656

Department of Clinical and Experimental Medicine, Centro Studio Ipertensione Arteriosa e Malattie Cardiorenali, Clinica e Terapia Medica, University of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002035DOI Listing
March 2019
4.720 Impact Factor

The evidence on the 2018 ESC/ESH Guidelines for the management of arterial hypertension in African ancestry patients.

J Hypertens 2019 Mar;37(3):650-651

Nelson R Mandela School of Medicine, Faculty of Health Sciences, University of KwaZulu Natal, Congella, Durban, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002024DOI Listing

Stroke, arterial hypertension and left ventricular mechanics.

Authors:
Marijana Tadic

J Hypertens 2019 Mar;37(3):498-500

Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001937DOI Listing

Is it time for clinical trials on indoor temperature and blood pressure?

Authors:
Joshua F Wiley

J Hypertens 2019 Mar;37(3):496-497

School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002031DOI Listing

Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO).

J Hypertens 2019 Mar;37(3):459-466

The Conway Institute, University College Dublin, Ireland.

: In the past 30 years, several organizations have developed protocols for clinical validation of blood pressure measuring devices. An international initiative was recently launched by the US Association for the Advancement of Medical Instrumentation (AAMI), the European Society of Hypertension Working Group on Blood Pressure Monitoring (ESH) and the International Organization for Standardization (ISO), aiming to reach consensus on a universal AAMI/ESH/ISO validation standard. The purpose of this statement by the ESH Working Group on Blood Pressure Monitoring is to provide practical guidance for investigators performing validation studies according to the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018), to ensure that its stipulations are meticulously implemented and data are fully reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002039DOI Listing
March 2019
5 Reads

Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: a post-hoc intention-to-treat analysis of the HIPARCO randomized clinical trial.

J Hypertens 2019 Jan 22. Epub 2019 Jan 22.

Respiratory Department, Hospital Universitario ValmE, Institute of Biomedicine of Seville (IBiS), Seville.

Rationale: Continuous positive airway pressure (CPAP) can significantly reduce blood pressure (BP) levels in patients with resistant hypertension and sleep apnea (OSA); however, the effect on patients with refractory hypertension (RfH) is not known. This study seeks to evaluate the effect of CPAP treatment on BP levels in patients with OSA and RfH, compared with those with OSA and resistant hypertension.

Methods: Post-hoc analysis of the HIPARCO randomized clinical trial on the effect of CPAP treatment on BP levels in patients with resistant hypertension. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002053DOI Listing
January 2019
3 Reads

Stable coronary artery disease: are there therapeutic benefits of heart rate lowering?

J Hypertens 2019 Jan 22. Epub 2019 Jan 22.

Division of Cardiology, New York University School of Medicine, New York, New York, USA.

: A physiologically lower heart rate, such as that seen in athletes, has been associated with better survival in epidemiological studies. In patients with coronary artery disease, heart rate is considered an independent risk factor for adverse outcomes. Higher heart rate increases cardiac work load and oxygen demand and reduces coronary perfusion by decreasing the amount of time spent in diastole, which in patients with obstructive coronary artery disease can trigger angina and myocardial infarction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002041DOI Listing
January 2019
6 Reads

Effect of antihypertensive therapy on development of incident conduction system disease in hypertensive patients.

J Hypertens 2019 Mar;37(3):629-635

Weill Cornell Medicine, New York, New York, USA.

Background: Previous work has demonstrated that treatment of hypertensive patients with the angiotensin-converting enzyme inhibitor lisinopril was associated with a reduced incidence of a composite conduction system disease endpoint and also left bundle branch block (LBBB) compared with chlorthalidone therapy. The relationship of incident conduction system disease to angiotensin receptor blocker therapy has not been examined.

Methods: Risk of new right (RBBB) or LBBB in relation to losartan-based vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001915DOI Listing
March 2019
2 Reads

The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction.

J Hypertens 2018 Dec 11. Epub 2018 Dec 11.

Department of Cardiology, University Clinical Hospital Center 'Dr Dragisa Misovic - Dedinje,' Heroja Milana Tepica, Belgrade, Serbia.

Objective: The influence of arterial hypertension on aortic stenosis severity is still controversial. The aim of this study was to evaluate the influence of hypertension on LV strain in patients with moderate and severe aortic stenosis.

Methods: This cross-sectional study included 115 patients with moderate and severe aortic stenosis and preserved LV ejection fraction (>50%) and 89 age-matched normotensive and hypertensive controls who underwent comprehensive echocardiographic examination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001963DOI Listing
December 2018
2 Reads

Diagnostic and therapeutical management of supine hypertension in autonomic failure: a review of the literature.

J Hypertens 2018 Dec 11. Epub 2018 Dec 11.

Autonomic Unit and Hypertension Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy.

: Supine hypertension is defined as a blood pressure at least 140 mmHg systolic or at least 90 mmHg diastolic in the supine position; supine hypertension is present in over 50% of patients with autonomic failure and orthostatic hypotension, but it is often overlooked. It may be related to antihypotensive drugs, but its presence in untreated patients suggests a neurogenic origin. Supine hypertension is often asymptomatic although it is associated with multiple organ damage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002008DOI Listing
December 2018
1 Read

A hybrid 4-item Krousel-Wood Medication Adherence Scale predicts cardiovascular events in older hypertensive adults.

J Hypertens 2018 Dec 11. Epub 2018 Dec 11.

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Background: There is a need for a brief, open access, self-report medication adherence scale that overcomes challenges of existing adherence tools, is associated with incident cardiovascular disease (CVD), and identifies low 'implementation' adherers to antihypertensive medications to facilitate blood pressure management.

Methods And Results: Antihypertensive medication adherence was assessed in a cohort of 1532 older hypertensive adults without prior CVD using the self-report 4-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4), a hybrid tool developed to predict pharmacy refill and which captures four domains of adherence behavior: self-efficacy, physical function, intentional medication-taking, and forgetfulness. The 4-item scale categorized participants as low and high adherers using scores at least 1 and less than 1, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001955DOI Listing
December 2018
3 Reads

Left ventricular hypertrophy identified by cardiac computed tomography and ECG in hypertensive individuals: a population-based study.

J Hypertens 2018 Dec 11. Epub 2018 Dec 11.

Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Denmark.

Objectives: Screening of left ventricular hypertrophy (LVH) is a biomarker of organ damage in hypertensive individuals and associated with increased mortality. Cardiac computed tomography (CT) is widely expanding worldwide; however, the value of CT assessment of LVH is unknown. We aimed to identify individuals with LVH using both cardiac CT and electrocardiograms (ECG) and to explore potential differences between these phenotypical distinct diagnostic modalities. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001962DOI Listing
December 2018
2 Reads

Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.

J Hypertens 2018 Dec 11. Epub 2018 Dec 11.

Department of Internal Medicine III, Saarland University Hospital, University of the Saarland, Kirrbergerstraße, Homburg/Saar.

Introduction: Epidemiological and clinical studies have shown a relevant association between heart rate and cardiovascular mortality. Experimental studies identified vascular effects of heart rate reduction with the If channel inhibitor ivabradine. Therefore, the effects of heart rate reduction on endothelial function and indices of arterial stiffness were examined in patients with stable coronary artery disease in a prospective, placebo-controlled clinical crossover study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001984DOI Listing
December 2018
1 Read

Highlights of the March issue.

Authors:
Giuseppe Mancia

J Hypertens 2019 Mar;37(3):457-458

Università Milano-Bicocca, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002045DOI Listing
March 2019
2 Reads

Patients' and healthcare providers' perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study.

J Hypertens 2019 Feb;37(2):389-397

Amsterdam Institute for Global Health and Development.

Background: In sub-Saharan Africa, cardiovascular disease is becoming a leading cause of death, with high blood pressure as number one risk factor. In Nigeria, access and adherence to hypertension care are poor. A pharmacy-based hypertension care model with remote monitoring by cardiologists through mHealth was piloted in Lagos to increase accessibility to quality care for hypertensive patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001877DOI Listing
February 2019
1 Read

Stiffening and ventricular-arterial interaction in the ascending aorta using MRI: ageing effects in healthy humans.

J Hypertens 2019 Feb;37(2):347-355

Brunel Institute for Bioengineering, Brunel University, Uxbridge, Middlesex, UK.

Objectives: The aim of this study was to investigate the effect of age and sex on nPWV and ndI in the ascending aorta of healthy humans.

Background: Local pulse wave velocity (nPWV) and wave intensity (ndI) in the human ascending aorta have not been studied adequately, because of the need for invasive pressure measurements. However, a recently developed technique made the noninvasive determination of nPWV and ndI possible using measurements of flow velocity and arterial diameter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001886DOI Listing
February 2019
1 Read

A clinical score for prediction of elevated aortic stiffness: derivation and validation in 3943 hypertensive patients.

J Hypertens 2019 Feb;37(2):339-346

Hypertension and Cardiometabolic Syndrome Unit, 1 Department of Cardiology, Medical School, National & Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

Objective: Aortic stiffness assessed by carotid-femoral pulse wave velocity (PWV) is an important predictor to gauge the overall risk of hypertensive patients; nonetheless, it is underutilized in everyday practice. We propose a simple scoring system based on clinical variables that can identify patients with a priority for measurement of PWV, that is, those with elevated PWV (≥10 m/s) and, consequently, at higher risk for events.

Methods: Patient data from three outpatient clinics (n = 3943) were used to form a derivation, internal and external validation cohort. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001904DOI Listing
February 2019
1 Read

Diet behaviours and hypertension in US adults: the National Health and Nutrition Examination Survey 2013-2014.

J Hypertens 2019 Jan 11. Epub 2019 Jan 11.

School of Public Health, Xi'an Jiaotong University Health Science Center.

Objective: The present study aims to explore the association between ideal diet behaviours recommended by the American Heart Association (AHA) and hypertension in the United States (US) adults using data from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.

Methods: Whole grains, fruits and vegetables, fish, sodium and sugar-sweetened beverages at an ideal level were defined as the AHA's recommendation. Associations between number of ideal diet behaviours and hypertension were assessed through multivariate logistic regression models. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002037DOI Listing
January 2019
1 Read

Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes.

J Hypertens 2019 Jan 11. Epub 2019 Jan 11.

Department of Epidemiology and Health Statistics, School of Public Health, Zhejiang University, Hangzhou.

Background: This study aimed to evaluate the impact of visit-to-visit variability (VVV) of blood pressure on the risk of diabetic nephropathy and whether it provides additional predictive information among patients with type 2 diabetes mellitus (T2DM) in China.

Methods: We included 12 630 T2DM patients during January 2008-December 2012 using a retrospective cohort design. VVV of SBP was assessed as standard deviation, coefficient of variation and variation independent of mean of the blood pressure readings during the measurement period. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004872-900000000-9728
Publisher Site
http://dx.doi.org/10.1097/HJH.0000000000002038DOI Listing
January 2019
6 Reads

Association between high-normal ankle-brachial index and hypertension incidence: the Okinawa Peripheral Arterial Disease Study.

J Hypertens 2019 Jan 11. Epub 2019 Jan 11.

Department of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus.

Objectives: Arterial stiffness is associated with longitudinal increases in blood pressure and hypertension development. A screened cohort was used to test whether increases in the ankle-brachial index (ABI) with age occur as a result of increasing arterial stiffness and wave reflection and is associated with hypertension incidence.

Methods: We analysed the data of 1344 participants without hypertension at baseline who underwent ABI measurements at least twice with an interval of at least 36 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001995DOI Listing
January 2019
1 Read

Reply.

J Hypertens 2019 Feb;37(2):455

Department of Public Health Solutions, National Institute for Health and Welfare.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001991DOI Listing
February 2019
1 Read

Electrocardiographic predictors of atrial fibrillation: prolonged P-wave and Bayés syndrome.

J Hypertens 2019 Feb;37(2):454-455

Department of Internal Medicine, Hospital Arquitecto Marcide, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001990DOI Listing
February 2019
1 Read

Reply.

J Hypertens 2019 Feb;37(2):454

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Saar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001993DOI Listing
February 2019
1 Read

Influence on renal blood flow in renal denervation procedures.

J Hypertens 2019 Feb;37(2):453-454

Division of Nephrology, Department of Internal Medicine, Shin-Kuki General Hospital, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001992DOI Listing
February 2019
1 Read

Reply.

J Hypertens 2019 Feb;37(2):452-453

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001996DOI Listing
February 2019
2 Reads

Systematic reviews: a small fraction of the evidence used to generate the 2017 clinical pediatric hypertension clinical practice guideline.

J Hypertens 2019 Feb;37(2):451-452

Departments of Pediatrics, Internal Medicine, Population and Quantitative Health Sciences, Center for Clinical Informatics Research and Education, Case Western Reserve University and the MetroHealth System, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001997DOI Listing
February 2019
1 Read

Reply.

J Hypertens 2019 Feb;37(2):449-451

Department of Cardiology, Sahlgrenska Academy at Gothenburg University, Gothenburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002012DOI Listing
February 2019
1 Read

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.

J Hypertens 2019 Feb;37(2):449

MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004872-201902000-0002
Publisher Site
http://dx.doi.org/10.1097/HJH.0000000000002011DOI Listing
February 2019
3 Reads

Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study.

J Hypertens 2019 Feb;37(2):365-371

Department of Internal Medicine, Maastricht University Medical Centre.

Introduction: Type 2 diabetes (T2D) is associated with cardiovascular disease complications such as myocardial infarction and stroke. These complications are at least partially the consequence of diabetes-associated increased arterial stiffness. Metformin, a first choice oral glucose-lowering drug, has been associated with potential cardio-protective effects. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001892DOI Listing
February 2019
1 Read

Prognostic value of blood pressure control delay in newly diagnosed hypertensive patients.

Authors:
Brent M Egan

J Hypertens 2019 Feb;37(2):290-291

Department of Medicine, University of South Carolina School of Medicine - Greenville, Care Coordination Institute, Greenville, South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001944DOI Listing
February 2019
1 Read

MRI-enabled noninvasive wave intensity analysis: an exciting tool for cardiovascular (patho)physiology research (in absence of local reflections).

Authors:
Patrick Segers

J Hypertens 2019 Feb;37(2):287-289

Institute Biomedical Technology, Ghent University, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001912DOI Listing
February 2019
1 Read

Orthostatic hypotension: is it a predictor of total and cardiovascular mortality in the elderly?

Authors:
Ehud Grossman

J Hypertens 2019 Feb;37(2):284-286

Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel HaShomer, Ramat Gan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001919DOI Listing
February 2019
1 Read

Malignant hypertension: not quite an obsolete diagnosis yet.

J Hypertens 2019 Feb;37(2):282-283

Institute of Cardiovascular Sciences, University of Birmingham, Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001974DOI Listing
February 2019
2 Reads

Left ventricular hypertrophy, arterial stiffness and blood pressure: exploring the Bermuda Triangle.

J Hypertens 2019 Feb;37(2):280-281

Cardiovascular Prevention and Research Unit, Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001973DOI Listing
February 2019
1 Read

First international consensus on the diagnosis and management of fibromuscular dysplasia.

J Hypertens 2019 Feb;37(2):229-252

Paris Descartes University.

: This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD) which was commissioned by the Working Group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). This document updates previous consensus documents/scientific statements on FMD published in 2014 with full harmonization of the position of European and US experts. In addition to practical consensus-based clinical recommendations, including a consensus protocol for catheter-based angiography and percutaneous angioplasty for renal FMD, the document also includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004872-201902000-0000
Publisher Site
http://dx.doi.org/10.1097/HJH.0000000000002019DOI Listing
February 2019
8 Reads

Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study.

J Hypertens 2019 Jan 9. Epub 2019 Jan 9.

CNR-IFC, Center of Clinical Physiology, Clinical Epidemiology of Renal Diseases and Hypertension.

Background: Neuropeptide Y (NPY) is a multifaceted sympathetic neurotransmitter regulating reflex cardiovascular control, myocardial cell growth, inflammation and innate immunity. Circulating NPY levels predict cardiovascular mortality in patients with end stage kidney disease on dialysis but this relationship has never been tested in predialysis chronic kidney disease (CKD) patients.

Methods: We investigated the relationship between circulating NPY and the risk for cardiovascular events (Fine & Gray competing risks model) in a cohort of 753 stages 2-5 CKD patients over a median follow-up of 36 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002030DOI Listing
January 2019
1 Read

Whole-exome sequencing in multiplex preeclampsia families identifies novel candidate susceptibility genes.

J Hypertens 2019 Jan 9. Epub 2019 Jan 9.

The Curtin/UWA Centre for Genetic Origins of Health and Disease, School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University.

Objective: Preeclampsia is a common and serious heritable disorder of human pregnancy. Although there have been notable successes in identification of maternal susceptibility genes a large proportion of the heritability of preeclampsia remains unaccounted for. It is has been postulated that rare variation may account for some of this missing heritability. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002023DOI Listing
January 2019
2 Reads

The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

Department of Internal Medicine, University of Milano-Bicocca, Hospital Monza/Milano, Milan, Italy.

: In 2010, 1.4 billion people globally had hypertension, with 14% controlled to systolic blood pressure (SBP, mmHg) below 140, which contributes to 18 million cardiovascular deaths annually. Recent hypertension guidelines endorsed SBP targets below 130 or lower for all or some hypertensive patients to reduce cardiovascular events (CVEs) more than the prior SBP target less than 140. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002021DOI Listing
January 2019
5 Reads

Updated systematic review and meta-analysis on the role of isometric resistance training for resting blood pressure management in adults.

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

Sports Research Centre, Miguel Hernández University of Elche, Alicante.

Background And Method: This meta-analysis sought to: quantify the effects of isometric resistance training (IRT) on the magnitude of change in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and resting heart rate in adults; and examine whether the magnitude of change in SBP, DBP, MAP and heart rate was different with respect to the patient demographic characteristics and IRT parameters. To be included in the meta-analysis, studies had to be randomized controlled trials lasting 2 or more weeks, investigating the effects of IRT on blood pressure in adults. The methodological quality of the studies selected was evaluated using the PEDro scale. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002022DOI Listing
January 2019
3 Reads

Arterial hypertension in patients under antineoplastic therapy: a systematic review.

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

First Department of Cardiology, 'Hippokration' Hospital, University of Athens, Medical School.

Background: Cardio-oncology aims to mitigate adverse cardiovascular manifestations in cancer survivors, but treatment-induced hypertension or aggravated hypertension has received less attention in these high cardiovascular risk patients.

Methods: In this systematic review, we searched literature for contemporary data on the prevalence, pathophysiologic mechanisms, treatment implications and preventive strategies of hypertension in patients under antineoplastic therapy.

Results: Several classes of antineoplastic drugs, including mainly vascular endothelial growth factor inhibitors, proteasome inhibitors, cisplatin derivatives, corticosteroids or radiation therapy were consistently associated with increased odds for new-onset hypertension or labile hypertensive status in previous controlled patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002006DOI Listing
January 2019
5 Reads

Increased carotid stiffness and remodelling at early stages of chronic kidney disease.

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

Department of Pharmacology, INSERM U970.

Objective: Increased carotid stiffness and remodelling is reported in patients with moderate and advanced chronic kidney disease (CKD) and is associated with cardiovascular events. Here, we tested the hypothesis that carotid artery alterations start earlier, during mild CKD.

Methods: Within the Paris Prospective Study 3, a large prospective observational survey of nonreferred people aged 50-75 who received an extensive health check-up, there were 294 participants with glomerular filtration rate (GFR) of at least 45 and less than 60 ml/min per 1. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004872-900000000-9729
Publisher Site
http://dx.doi.org/10.1097/HJH.0000000000002007DOI Listing
January 2019
5 Reads

A retrospective study of arterial stiffness and subsequent clinical outcomes in cancer patients undergoing percutaneous coronary intervention.

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

Department of Cardiovascular Medicine.

Objective: Increasing attention is being paid to the relationship between cancer and cardiovascular diseases. In this study, we examined arterial stenosis and stiffness in patients with malignant diseases requiring percutaneous coronary intervention.

Methods: This was a retrospective, single-center, observational study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001949DOI Listing
January 2019
2 Reads

Impact of early initiation of antihypertensive medications for patients with hypertension or elevated blood pressure.

J Hypertens 2019 Jan 7. Epub 2019 Jan 7.

Department of Pharmaceutical and Health Economics, School of Pharmacy, Leonard Schaeffer Center for Health Policy and Economics.

Objectives: The 2017 American College of Cardiology/American Heart Association High Blood Pressure Guidelines lowered high blood pressure (BP) threshold, recommending earlier treatment to prevent cardiovascular disease. This study estimated the impact of initiating early antihypertensive medications on the risk of acute myocardial infarction (AMI), stroke, death, and on healthcare costs in patients potentially qualifying for antihypertensive treatment under the 2017 guidelines.

Methods: High-risk patients qualifying for antihypertensive medications under the 2017 guidelines were identified using Optum data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002014DOI Listing
January 2019
2 Reads